Thank you, Madam Chair.
Mr. Outterson, your work shows that inaction on antimicrobial resistance could cost the global economy trillions of dollars by 2050. However, the required investment would amount to a few billion dollars per year.
In your opinion, why is it taking so long for Canada to act, despite such an economic performance?
Do you have concrete estimates on what an effective investment plan would yield compared to the cost of inaction?